Literature DB >> 11007776

A single dose of methamphetamine leads to a long term reversal of the blunted dopamine D1 receptor-mediated neocortical c-fos responses in mice deficient for D2 and D3 receptors.

C Schmauss1.   

Abstract

Dopamine D(1) receptors play an essential role in the induction of expression of the immediate-early gene c-fos in response to pharmacological stimuli. In the forebrain of wild-type mice, administration of a D(1) receptor agonist leads to c-fos mRNA expression levels that are substantially higher than corresponding levels expressed after indirect stimulation of dopamine receptors with methamphetamine. In mice deficient for D(2) and D(3) receptors, c-fos mRNA levels expressed in response to D(1) agonist administration are significantly blunted. However, a single dose of methamphetamine (5 mg/kg) leads to a long lasting reversal of the blunted c-fos responses in these mutants. In the forebrain, this reversal is restricted to the neocortex. Moreover, methamphetamine also enhances c-fos expression levels in preadolescent wild-type mice that normally express low c-fos mRNA in response to D(1) agonist stimulation. Thus, a single dose of methamphetamine leads to a long term increase in D(1) receptor-dependent c-fos responses in brains with either low (preadolescent mice) or blunted (adult D(2) and D(3) mutant mice) c-fos expression levels. A similar long term reversal of the blunted c-fos responses is achieved with a single dose of a full D(1) agonist. These results indicate that the constitutive inactivation of D(2) and D(3) receptors leads to a decrease in agonist-promoted D(1) receptor activity that can be reversed by intermittent agonist stimulation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11007776     DOI: 10.1074/jbc.M005064200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  Dopamine D3 receptor: A neglected participant in Parkinson Disease pathogenesis and treatment?

Authors:  Pengfei Yang; Joel S Perlmutter; Tammie L S Benzinger; John C Morris; Jinbin Xu
Journal:  Ageing Res Rev       Date:  2019-11-22       Impact factor: 10.895

2.  The effects of pramipexole on prepulse inhibition and locomotor activity in C57BL/6J mice.

Authors:  Wei-Li Chang; Mark A Geyer; Mahalah R Buell; Martin Weber; Neal R Swerdlow
Journal:  Behav Pharmacol       Date:  2010-03       Impact factor: 2.293

3.  Imaging cerebral gene transcripts in live animals.

Authors:  Christina H Liu; Young R Kim; Jia Q Ren; Florian Eichler; Bruce R Rosen; Philip K Liu
Journal:  J Neurosci       Date:  2007-01-17       Impact factor: 6.167

4.  Chronic Methamphetamine Causes Differential Expression of Immediate Early Genes in the Nucleus Accumbens and Midbrain of Rats.

Authors:  Tiffany Garrett; Ingrid Tulloch; Michael T McCoy; Bruce Ladenheim; Subramaniam Jayanthi; Irina Krasnova; Genevieve Beauvais; Amber Hodges; Carolyn Davis; Jean Lud Cadet
Journal:  J Drug Alcohol Res       Date:  2012

5.  Drug-induced activation of dopamine D(1) receptor signaling and inhibition of class I/II histone deacetylase induce chromatin remodeling in reward circuitry and modulate cocaine-related behaviors.

Authors:  Frederick A Schroeder; Krista L Penta; Anouch Matevossian; Sara R Jones; Christine Konradi; Andrew R Tapper; Schahram Akbarian
Journal:  Neuropsychopharmacology       Date:  2008-02-20       Impact factor: 7.853

6.  Mice lacking dopamine D2 and D3 receptors have spatial working memory deficits.

Authors:  Sara B Glickstein; Patrick R Hof; Claudia Schmauss
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

7.  Role of dopamine D1-like receptors in methamphetamine locomotor responses of D2 receptor knockout mice.

Authors:  M A Kelly; M J Low; M Rubinstein; T J Phillips
Journal:  Genes Brain Behav       Date:  2008-07       Impact factor: 3.449

Review 8.  Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice.

Authors:  Chunyu Zeng; Ines Armando; Yingjin Luo; Gilbert M Eisner; Robin A Felder; Pedro A Jose
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-12-14       Impact factor: 4.733

Review 9.  Dopamine receptors and Parkinson's disease.

Authors:  Shin Hisahara; Shun Shimohama
Journal:  Int J Med Chem       Date:  2011-06-13

10.  Dopamine receptor 3 might be an essential molecule in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity.

Authors:  Yan Chen; Ying-yin Ni; Jie Liu; Jia-wei Lu; Fang Wang; Xiao-lin Wu; Ming-min Gu; Zhen-yu Lu; Zhu-gang Wang; Zhi-hua Ren
Journal:  BMC Neurosci       Date:  2013-07-31       Impact factor: 3.288

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.